New bladder cancer treatment gets EU nod

Eight months after receiving approval from the U.S. Food and Drug Administration (FDA), a new treatment for metastatic bladder cancer has received a positive opinion from the Committee for Medicinal Products for Human Use (CHMP) of the European…